Question

A client who developed syndrome of inappropriate antidiuretic hormone (SIADH) associated with small carcinoma of the lung is preparing for discharge. When teaching the client about self-management with demeclocycline (Declomycin), the nurse should instruct the client to report which condition to the health care provider?

Answer 1

The nurse should instruct the SIADH client on demeclocycline to report signs of dehydration or electrolyte imbalance, such as confusion or nausea, to the healthcare provider.

Step-by-step explanation:

When instructing a client who is preparing for discharge with demeclocycline for the treatment of a syndrome of inappropriate antidiuretic hormone (SIADH) associated with small cell carcinoma of the lung, the nurse must emphasize the importance of reporting specific symptoms that could indicate serious side effects from the medication. The key side effect that should prompt immediate contact with the healthcare provider is the development of dehydration or symptoms suggestive of an imbalance in electrolytes, such as confusion, lethargy, nausea, or seizures, which can be indicative of hyponatremia.

Demeclocycline helps manage SIADH by reducing the water reabsorption effects of antidiuretic hormone (ADH), also known as vasopressin, which in SIADH is produced in excess. However, this action can lead to dehydration and an altered balance of electrolytes in the body, especially sodium, and careful monitoring is necessary to prevent complications.